Profile

Highly successful career pathway with 30 years of international health care experience, including 12 years at J&J and most recently as Vice President of Sales and Marketing in a med-tech startup.

Unique experience portfolio that started as head of the Department of Interventional Cardiology in a University Hospital followed by extensive international experience in medical device multinationals and startups.

Demonstrated ability to adapt and thrive in a wide range of cultures and environment

Career Overview / Bio

(*) as Executive Consultant

January 2013 - Today: CALIBER THERAPEUTICS, NY US

Vice President of Operations (*)

2012 - 2013: SURPASS MEDICAL INC. FL US

International Vice President of Sales and Marketing (*)

Launched Surpass’ technology in the complex area of interventional neuroradiology by recruiting staff, building commercial platform and develop a strong supporting KOL network. The company got acquired by Stryker in November 2012 for $135M.

2009 – 2011: STENTYS SAS. Paris, France

Vice President of Sales and Marketing.

Turned around the company’s strategic focus thus laying the base for targeted commercialization of its pioneering technology

Defined and implemented both Europe-wide and country-specific business development strategies through solid KOL-, Health Economics- (e.g. NUB Status 1 in Germany), Clinical- and Geographical Expansion initiatives

Hit or exceeded all company milestones: 2010 and 2011YTD revenues; timely recruitment of top class European commercial team consisting of 11 senior business leaders and marketers; timely enrollment in clinical trials; consistent communication and strong KOL endorsement.

In one year, managed to establish a strong commercial footprint in 15 target countries through a unique balance of seasoned sales executives and a selection of highly motivated distributors.

2006 – 2009: CORDIS JOHNSON & JOHNSON, Brussels Belgium

Director of Marketing Endovascular EMEA

Member of the EMEA board

3 major launches of disruptive technologies for the treatment of obstructive vascular low limb disease supported by a multidisciplinary team